NCT04993677 2025-05-11A Study of SEA-CD40 Given With Other Drugs in CancersSeagen Inc.Phase 2 Completed77 enrolled 18 charts
NCT04452214 2023-07-14A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid TumorsCantargia ABPhase 1 Completed19 enrolled